bioRxivBioinformaticsPreprint
Boolean Logic Coupled with Overrepresentation Analysis Reveals Activation of the Platelet-derived Growth Factor Receptor Beta Pathway in a Model of Oliguric Acute Kidney Injury; Implications for Transition to Chronic Kidney Disease
Hiral M Chavre, Terrence Bissoondial, Mahesh NarayaniD, Prakash Narayan AiD
Abstract
Acute Kidney Injury (AKI) can occur secondary to insults including sepsis, ischemia and contrast dye administration. A time-sensitive increase in serum creatinine (SCr) or reduction in urine output (UO) has been used to define AKI and stage its severity. Oliguria or significantly reduced UO in AKI or oliguric AKI can have a major impact on outcomes including a transition to chronic kidney disease (CKD). We used Boolean logic coupled with overrepresentation analysis to identify the pathway activation signature associated with oliguric AKI in a published study of rat kidney-ischemia reperfusion. In the reperfused kidney, bulk transcriptomic analysis revealed 1068 differentially expressed genes (DEGs). Those DEGs that correlated with UO and SCr were submitted to gene ontology biological process overexpression analysis. The pathway activation signature associated with oliguric AKI included positive regulation of profibrotic platelet-derived growth factor receptor beta signaling (fold-enrichment >44) driven by src, hip1 and hip1r. Together these findings not only suggest that oliguric AKI may be associated with activation of a pathway leading to fibrosis and CKD but also informs an array of targets to potentially mitigate transition to CKD. HighlightsMechanistic insights should illuminate therapies. A model of rat kidney-ischemia reperfusion injury was queried by correlating kidney transcriptomics with kidney function to identify the pathway activation signature of oliguric AKI. The most striking feature associated with oliguric AKI was positive regulation of platelet-derived growth factor receptor {beta} driven by src, hip1, and hip1r. The pathway activation signature in oliguric AKI informs not only the sequel to injury but also an array of targets to mitigate the potential transition to kidney fibrosis and CKD. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=47 SRC="FIGDIR/small/680804v1_ufig1.gif" ALT="Figure 1"> View larger version (14K): org.highwire.dtl.DTLVardef@121edc1org.highwire.dtl.DTLVardef@80383borg.highwire.dtl.DTLVardef@1ebc25dorg.highwire.dtl.DTLVardef@1258145_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: rat
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Acute kidney injury-induced circulating TNFR1/2 elevations correlate with persistent kidney injury and progression to fibrosis
A. Arthanarisami, Y. Komaru, … E. Kefaloyianni·CellsPeer-reviewed·Sep 5, 2023
- EGFR-driven profibrotic signals in AKI-to-CKD transition are blocked by TNF inhibition: Opportunities for etanercept treatment
M. M. Abdelmageed, E. Kefaloyianni, … A. Herrlich·bioRxiv·Apr 29, 2021
- Peripheral CB1R Blockade Suppresses AKI-to-CKD Maladaptive Repair
Ariel Rothner, Liad Hinden, … Joseph Tam·bioRxiv·Aug 5, 2026
- Cytokines in the Urine of AKI patients regulate TP53 and SIRT1 and can be used as biomarkers for the early detection of AKI
Lars Erichsen, Chantelle Thimm, … James Adjaye·bioRxiv·Jan 20, 2023
- Inflammation-mediated Upregulation of VCAM-1 but not KIM-1 during Acute Kidney Injury to Chronic Kidney Disease Transition
I. Melchinger, K. Guo, … L. Xu·bioRxiv·Sep 15, 2022
- Immune-mediated Tubule Atrophy Promotes Acute Kidney Injury to Chronic Kidney Disease Transition
L. Xu, J. Guo, … L. G. Cantley·bioRxiv·Jun 1, 2022